Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 10NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 18Leukemia, Myeloid, Acute 17Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Congenital Abnormalities 10Lymphoma 8Leukemia, Myeloid, Chronic-Phase 8Neoplasms, Plasma Cell 7Multiple Myeloma 7Leukemia, Myelomonocytic, Chronic 7Neuroblastoma 6Leukemia, Myelomonocytic, Acute 6Anemia, Refractory, with Excess of Blasts 6Myeloproliferative Disorders 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Erythroblastic, Acute 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Hodgkin Disease 4Sarcoma 3

Interventions

Cytarabine 6Idarubicin 4Vorinostat 3Tretinoin 3Etoposide 3Daunorubicin 3Azacitidine 3romidepsin 2Thioguanine 2Sorafenib 2Radiotherapy 2Mitoxantrone 2Methotrexate 2Mercaptopurine 2Lenalidomide 2Cyclophosphamide 2sargramostim 1perifosine 1octadecyl-(N,N-dimethylpiperidino-4-yl)-phosphate 1merphos 1ispinesib 1flt3 ligand protein 1entinostat 1belinostat 1Peripheral Blood Stem Cell Transplantation 1Homoharringtonine 1Filgrastim 1Drug Therapy 1Decitabine 1CK0238273 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Promyelocytic, Acute × Busulfan × Clear all
NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡